Compare Amphastar Pharmaceuticals Inc (AMPH) vs Centrus Energy Corp (LEU) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

Centrus Energy (LEU) trades at $171.05, down 1.45% on the day, with a neutral technical outlook. The company recently secured a major Department of Energy contract valued over $1 billion and is set to join the S&P SmallCap 600 index. While Q1 2026 earnings beat expectations, Q4 2025 was a significant miss. Valuation ratios appear elevated with a P/E of 62.2 and P/S of 8.05. Operating cash flow was positive in 2025 but turned negative in 2026 projections.

The outlook is mixed; strong government contracts and index inclusion provide tailwinds, but high valuation and inconsistent earnings pose risks. Analyst consensus is a Buy with a $224.50 price target, suggesting potential upside, though execution on new contracts and profitability trends will be critical for sustained growth.